CHICAGO, February 6, 2015 – Mesirow Financial acted as the exclusive financial advisor to The Flexan Corporation (“Flexan” or the “Company”) on its sale to Linden Capital Partners (“Linden”), a Chicago-based healthcare private equity firm.
Headquartered in Chicago, Illinois, the Company operates manufacturing facilities in the greater Chicago area and China under two distinct, but complementary business units, FMI, Inc. (“FMI”) and Flexan. FMI delivers clean room-manufactured silicone molded components for use in Class II disposable and Class III implantable medical devices. Flexan is a custom molder with expertise in molding difficult geometries, bonding rubber to metal and other substrates and delivering high precision, niche parts to a range of industries, including hearing technology, commercial and industrial.
Scott Severson, CEO of Flexan, commented, “Mesirow Financial’s expert guidance and unwavering support from start to finish was instrumental in securing a successful outcome for our shareholders and we are thrilled to have a partner like Linden who is committed to our continued growth.”
Jeff Golman, vice chairman and head of Mesirow Financial’s Investment Banking group said, “Mesirow Financial was honored to represent the owners of Flexan. We believe the Company’s unique expertise, coupled with its leading position in highly attractive end-markets, presents an exciting future.”
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. Linden's strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit lindenllc.com.